These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7019366)

  • 1. The acute effects of sustained volume expansion on the renin-aldosterone system and renal function in human hepatic ascites.
    Greig PD; Blendis LM; Langer B; Ruse J; Taylor BR
    J Lab Clin Med; 1981 Jul; 98(1):127-34. PubMed ID: 7019366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
    Blendis LM; Greig PD; Langer B; Baigrie RS; Ruse J; Taylor BR
    Gastroenterology; 1979 Aug; 77(2):250-7. PubMed ID: 447039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal and hemodynamic effects of the peritoneovenous shunt. II. Long-term effects.
    Greig PD; Blendis LM; Langer B; Taylor BR; Colapinto RF
    Gastroenterology; 1981 Jan; 80(1):119-25. PubMed ID: 7004991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of peritoneovenous shunting in unravelling the pathogenesis of ascites in cirrhosis.
    Blendis LM
    Isr J Med Sci; 1986 Feb; 22(2):78-80. PubMed ID: 3512475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved renal function and inhibition of renin and aldosterone secretion following peritoneovenous (LeVeen) shunt.
    Berkowitz HD; Mullen JL; Miller LD; Rosato EF
    Surgery; 1978 Jul; 84(1):120-6. PubMed ID: 663820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta adrenergic blocking drugs on the renin-aldosterone system, sodium excretion, and renal hemodynamics in cirrhosis with ascites.
    Wilkinson SP; Bernardi M; Smith IK; Jowett TP; Slater JD; Williams R
    Gastroenterology; 1977 Oct; 73(4 Pt 1):659-63. PubMed ID: 19338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters.
    Quiroga J; Sangro B; Núñez M; Bilbao I; Longo J; García-Villarreal L; Zozaya JM; Betés M; Herrero JI; Prieto J
    Hepatology; 1995 Apr; 21(4):986-94. PubMed ID: 7705810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin-angiotensin-aldosterone system in human hepatic cirrhosis.
    Bernardi M; Gasbarrini G
    Isr J Med Sci; 1986 Feb; 22(2):70-7. PubMed ID: 3512474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting.
    Reznick RK; Langer B; Taylor BR; Seif S; Blendis LM
    Gastroenterology; 1983 Apr; 84(4):713-8. PubMed ID: 6337910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dipyridamole on kidney function in cirrhosis.
    Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J
    Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W; Liu P; Blendis L; Wong F
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamics, compartments and the renin-aldosterone system in chronic heart failure.
    Hesse B; Nielsen I; Bollerup AC; Olesen KH; Uhrenholdt A
    Eur J Cardiol; 1975 Aug; 3(2):107-15. PubMed ID: 1183461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of ascites and renal salt retention in cirrhosis.
    Palmer BF
    J Investig Med; 1999 May; 47(5):183-202. PubMed ID: 10361377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine response to plasma volume expansion during the early postoperative period in heart transplant recipients.
    Mertes PM; de Talancé N; Carteaux JP; Pinelli G; Dopff C; Burtin P; Villemot JP; Burlet C; Boulangé M
    J Heart Lung Transplant; 1993; 12(6 Pt 1):1001-8. PubMed ID: 8312300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.